Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease

Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease

This review describes targeting neutrophils as a potential therapeutic strategy for acute respiratory distress syndrome (ARDS) associated with coronavirus disease 2019 (COVID-19), a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neutrophil counts are significantly e...

Full description

Bibliographic Details
Main Authors: Chih-Chao Chiang, Michal Korinek, Wei-Jen Cheng, Tsong-Long Hwang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Pharmacology
Subjects:
coronavirus disease 2019
severe acute respiratory syndrome coronavirus 2
acute respiratory distress syndrome
neutrophils
neutrophil extracellular trap
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.572009/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.572009/full

Similar Items